SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001517022-24-000046
Filing Date
2024-04-25
Accepted
2024-04-25 17:18:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defanotice.htm DEFA14A 12444
2 GRAPHIC akebianotice001.jpg GRAPHIC 164574
3 GRAPHIC akebianotice002.jpg GRAPHIC 133184
  Complete submission text file 0001517022-24-000046.txt   423689
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36352 | Film No.: 24877523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)